Fig. 6
From: Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
Case 65: a 38-year-old male, with mild obesity, no other comorbidities, score 7 under vasopressor treatment. Chest X-ray: a day of inclusion (April 16th). Extensive consolidations involving both lung fields with left retrocardiac volume loss. Blunting of the left CP angle. Ill-defined opacities seen in bilateral lower zones. b Day 4 after treatment (April 20th). Improved appearance of patchy airspace opacity in the whole left lung with almost resolved bilateral pleural effusion and underlying atelectasis; however, consolidation is again noted in the left retrocardiac area with mild worsening of airspace opacity in the right mid and lower zones. c Day 9 after treatment (April 25th). Regression of patchy airspace opacification mid-right and left lung when compared to the previous study. Residual patchy bilateral airspace opacification particularly in the left retrocardiac region